Ingredient in GSK's HIV drugs linked to heart attacks

08/7/2008 | Bloomberg

Abacavir, an active ingredient in GlaxoSmithKline's HIV treatments Ziagen and Epzicom, is associated with a higher risk of heart attack in older patients, according to a Danish study. The findings support previous data that prompted GSK to add a warning to Ziagen's prescribing information last month.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations